invivodata Announces Drug Information Association (DIA) Annual Meeting Activities

invivodata Announces Drug Information Association (DIA) Annual Meeting
Activities

Senior Scientific and Executive Team Members to be Featured Speakers

PITTSBURGH, June 16 /PRNewswire/ -- invivodata inc., the industry leader in
electronic patient reported outcomes (ePRO) solutions and services for global
clinical research, today announced that members of its senior scientific and
executive management team will be featured speakers at the Drug Information
Association (DIA) 45th Annual Meeting in San Diego, Calif., June 21-25, 2009.

This is the eighth consecutive year that invivodata has had a significant
presence at this global industry event. Representing invivodata at this
year's meeting are:

-- Dr. Jean Paty, invivodata's senior vice president of scientific,
quality, and regulatory affairs, will participate in "Computerized
Systems Used in Clinical Research: Best Practices from Peach - Part 2
of 2" with a presentation on "Highlights from the Chapter on
Data Collection"; Tues., June 23, 4:00 pm PDT
-- Doug Engfer, invivodata's president and chief executive officer,
will present "The Role of eDiaries in Monitoring Patient Compliance
in Clinical Trials"; Tues., June 23, 4:00 pm PDT

-- Dr. Jean Paty will present "Using Handhelds to Collect Patient
Data" as part of the session "Unique Challenges for
Validation"; Thurs., June 25, 10:30 am PDT

In Booth No. 1706, invivodata will showcase its global ePRO solutions,
including DiaryPRO(R) 210, its proven field-based electronic diary delivered
on the Windows Mobile operating system and the Hewlett-Packard iPAQ(R) 210
device. invivodata will also be demonstrating its large-screen, site-based
ePRO solution - the SitePRO(R) Tablet, which offers significant efficiencies
by eliminating the time-intensive management of paper-based assessments
typically completed by trial subjects during site visits.
Additionally, regulatory and scientific experts from invivodata and its
consulting division, PRO Consulting(TM) will be available to answer questions
about PRO strategy development and selecting the right PRO measures and
methods to assess treatment effect in support of regulatory submissions.
For more information on invivodata's DIA activities, please visit
www.invivodata.com.

About invivodata inc.
invivodata combines behavioral science, information technology, and clinical
research expertise to capture high quality clinical trial data directly from
patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions,
which are based on over 20 years of research, deliver reliable patient
self-reported data by driving patient compliance with the protocol and
eliminating recall biases that plague paper-based self-report data.
invivodata's solutions include comprehensive trial-support services that
facilitate the collection of ePRO data, web-based access to study data and
operational reports that give researchers and sponsors visibility into study
progress, and scientific and regulatory consulting on the use of PRO data in a
regulated environment. invivodata's solution has been used in more than 275
clinical programs and is the industry-leading ePRO system in delivering
primary efficacy data for FDA drug approvals. invivodata inc. is a privately
held company with global headquarters in Pittsburgh, Pa., USA; its European
headquarters are in London, England; and its technology development center is
in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

For more information, contact:

invivodata inc.
Christine Tobin
Corporate Communications Specialist
(412) 390-3000, ext. 3502
ctobin@invivodata.com

SOURCE invivodata inc.

Christine Tobin, Corporate Communications Specialist, invivodata inc.,
+1-412-390-3000, ext. 3502, ctobin@invivodata.com